Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARD | Q03181 | 15/20 | 0.41 |
| ▸ | PPARA | Q07869 | 14/20 | 0.41 |
| ▸ | PPARG | P37231 | 11/20 | 0.41 |
| ▸ | AGER | Q15109 | 1/20 | 0.37 |
| ▸ | GPR119 | Q8TDV5 | 2/20 | 0.36 |
| ▸ | FBP1 | P09467 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4679968 | 0.93 | PPARA (0.48) | PPARDPPARAPPARG | |
| SCHEMBL4679129 | 0.78 | PPARD (0.42) | PPARDPPARAPPARGFBP1 | |
| SCHEMBL4682147 | 0.78 | PPARD (0.41) | PPARDPPARAPPARGFBP1 | |
| SCHEMBL4682146 | 0.78 | PPARA (0.45) | PPARDPPARAPPARGAGERFBP1 | |
| SCHEMBL14445956 | 0.76 | PPARA (0.46) | PPARDPPARAPPARGFBP1 | |
| SCHEMBL4679123 | 0.76 | PPARA (0.45) | PPARDPPARAPPARGGPR119FBP1 | |
| SCHEMBL4682140 | 0.75 | PPARA (0.43) | PPARDPPARAPPARGAGERGPR119 | |
| SCHEMBL14445913 | 0.74 | FBP1 (0.45) | PPARDPPARAPPARGFBP1 | |
| SCHEMBL4102563 | 0.73 | PPARD (0.38) | PPARDPPARAPPARGFBP1 | |
| SCHEMBL5188242 | 0.72 | PPARD (0.39) | PPARDPPARAPPARGFBP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1513796-B1 | PHENYLOXYALKANOIC ACID DERIVATIVES AS HPPAR ACTIVATORS | SMITHKLINE BEECHAM CORP (US) | 2008-02-13 | — | — | EP | claimed |
| US-7241793-B2 | Phenyloxyalkanonic acid derivatives as hPPAR activators | SMITHKLINE BEECHAM CORPORATION (US) | 2007-07-10 | — | — | US | claimed |
| US-20050222424-A1 | Phenyloxyalkanonic acid derivatives as hppar activators | SMITHKLINE BEECHAM CORPORATION | 2005-10-06 | — | — | US | claimed |
| EP-1513796-B1 | PHENYLOXYALKANOIC ACID DERIVATIVES AS HPPAR ACTIVATORS | SMITHKLINE BEECHAM CORP (US) | 2008-02-13 | — | — | EP | disclosed |
| US-7241793-B2 | Phenyloxyalkanonic acid derivatives as hPPAR activators | SMITHKLINE BEECHAM CORPORATION (US) | 2007-07-10 | — | — | US | disclosed |
| US-20050222424-A1 | Phenyloxyalkanonic acid derivatives as hppar activators | SMITHKLINE BEECHAM CORPORATION | 2005-10-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050222424-A1 | Phenyloxyalkanonic acid derivatives as hppar activators | CEL, HPN, LIPA | PPARD 223/4885PPARA 54/4885PPARG 70/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.